| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | SETX DNAH10 ATAD5 ZGRF1 SMC1A SMC6 RSF1 CHD2 KIF20B SMARCA1 MACF1 DNAH6 HSPA6 | 2.74e-05 | 614 | 108 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.62e-05 | 127 | 108 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.40e-04 | 441 | 108 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH10 ATAD5 SMC1A SMC6 RSF1 CHD2 KIF20B RABL2B RABL2A GNL2 MACF1 DNAH6 HSPA6 | 2.82e-04 | 775 | 108 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH10 ATAD5 SMC1A SMC6 RSF1 CHD2 KIF20B RABL2B RABL2A GNL2 MACF1 DNAH6 HSPA6 | 5.99e-04 | 839 | 108 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH10 ATAD5 SMC1A SMC6 RSF1 CHD2 KIF20B RABL2B RABL2A GNL2 MACF1 DNAH6 HSPA6 | 6.06e-04 | 840 | 108 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH10 ATAD5 SMC1A SMC6 RSF1 CHD2 KIF20B RABL2B RABL2A GNL2 MACF1 DNAH6 HSPA6 | 6.06e-04 | 840 | 108 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.05e-03 | 37 | 108 | 3 | GO:0140658 | |
| Domain | Spectrin | 7.40e-06 | 23 | 104 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 1.94e-05 | 29 | 104 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 2.89e-05 | 32 | 104 | 4 | IPR018159 | |
| Domain | SPEC | 2.89e-05 | 32 | 104 | 4 | SM00150 | |
| Domain | TPR_REGION | 3.83e-05 | 165 | 104 | 7 | PS50293 | |
| Domain | TPR | 3.83e-05 | 165 | 104 | 7 | PS50005 | |
| Domain | UIM | 1.29e-04 | 18 | 104 | 3 | PF02809 | |
| Domain | UIM | 2.07e-04 | 21 | 104 | 3 | SM00726 | |
| Domain | TPR_8 | 2.15e-04 | 53 | 104 | 4 | PF13181 | |
| Domain | P-loop_NTPase | SETX DNAH10 ATAD5 ZGRF1 SMC1A SMC6 CHD2 HNRNPUL1 KIF20B RABL2B RABL2A GNL2 SMARCA1 DNAH6 | 2.53e-04 | 848 | 104 | 14 | IPR027417 |
| Domain | - | SETX DNAH10 ATAD5 ZGRF1 SMC1A SMC6 CHD2 HNRNPUL1 RABL2B RABL2A GNL2 SMARCA1 DNAH6 | 2.55e-04 | 746 | 104 | 13 | 3.40.50.300 |
| Domain | Actinin_actin-bd_CS | 2.74e-04 | 23 | 104 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 2.74e-04 | 23 | 104 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.74e-04 | 23 | 104 | 3 | PS00019 | |
| Domain | UIM | 3.12e-04 | 24 | 104 | 3 | PS50330 | |
| Domain | UIM_dom | 3.53e-04 | 25 | 104 | 3 | IPR003903 | |
| Domain | SANT_dom | 3.97e-04 | 26 | 104 | 3 | IPR017884 | |
| Domain | - | 4.54e-04 | 6 | 104 | 2 | 3.90.1290.10 | |
| Domain | ENTH | 4.54e-04 | 6 | 104 | 2 | PF01417 | |
| Domain | GAR | 4.54e-04 | 6 | 104 | 2 | PS51460 | |
| Domain | - | 4.54e-04 | 6 | 104 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 4.54e-04 | 6 | 104 | 2 | IPR003108 | |
| Domain | GAS2 | 4.54e-04 | 6 | 104 | 2 | PF02187 | |
| Domain | GAS2 | 4.54e-04 | 6 | 104 | 2 | SM00243 | |
| Domain | CH | 4.73e-04 | 65 | 104 | 4 | SM00033 | |
| Domain | SANT | 4.97e-04 | 28 | 104 | 3 | PS51293 | |
| Domain | CH | 6.27e-04 | 70 | 104 | 4 | PF00307 | |
| Domain | Plectin_repeat | 6.33e-04 | 7 | 104 | 2 | IPR001101 | |
| Domain | Plectin | 6.33e-04 | 7 | 104 | 2 | PF00681 | |
| Domain | PLEC | 6.33e-04 | 7 | 104 | 2 | SM00250 | |
| Domain | - | 6.62e-04 | 71 | 104 | 4 | 1.10.418.10 | |
| Domain | CH | 7.35e-04 | 73 | 104 | 4 | PS50021 | |
| Domain | TPR | 7.74e-04 | 129 | 104 | 5 | SM00028 | |
| Domain | CH-domain | 8.14e-04 | 75 | 104 | 4 | IPR001715 | |
| Domain | RecF/RecN/SMC_N | 8.41e-04 | 8 | 104 | 2 | IPR003395 | |
| Domain | SMC_N | 8.41e-04 | 8 | 104 | 2 | PF02463 | |
| Domain | TPR_repeat | 8.89e-04 | 133 | 104 | 5 | IPR019734 | |
| Domain | - | 1.06e-03 | 207 | 104 | 6 | 1.25.40.10 | |
| Domain | ENTH | 1.08e-03 | 9 | 104 | 2 | PS50942 | |
| Domain | ENTH | 1.08e-03 | 9 | 104 | 2 | SM00273 | |
| Domain | GDS_CDC24_CS | 1.33e-03 | 39 | 104 | 3 | IPR001331 | |
| Domain | ENTH | 1.34e-03 | 10 | 104 | 2 | IPR013809 | |
| Domain | TPR-contain_dom | 1.52e-03 | 150 | 104 | 5 | IPR013026 | |
| Domain | - | 1.54e-03 | 391 | 104 | 8 | 2.30.29.30 | |
| Domain | TPR-like_helical_dom | 1.94e-03 | 233 | 104 | 6 | IPR011990 | |
| Domain | PH_dom-like | 2.62e-03 | 426 | 104 | 8 | IPR011993 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.68e-03 | 14 | 104 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.68e-03 | 14 | 104 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.68e-03 | 14 | 104 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.68e-03 | 14 | 104 | 2 | PF08393 | |
| Domain | MT | 2.68e-03 | 14 | 104 | 2 | PF12777 | |
| Domain | AAA_8 | 2.68e-03 | 14 | 104 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.68e-03 | 14 | 104 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.68e-03 | 14 | 104 | 2 | PF07728 | |
| Domain | SANT | 2.72e-03 | 50 | 104 | 3 | SM00717 | |
| Domain | SANT/Myb | 3.04e-03 | 52 | 104 | 3 | IPR001005 | |
| Domain | DHC_fam | 3.08e-03 | 15 | 104 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.08e-03 | 15 | 104 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.08e-03 | 15 | 104 | 2 | PF03028 | |
| Domain | ARM-like | 4.02e-03 | 270 | 104 | 6 | IPR011989 | |
| Domain | PH | 4.63e-03 | 278 | 104 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.71e-03 | 279 | 104 | 6 | PS50003 | |
| Domain | PH_domain | 4.79e-03 | 280 | 104 | 6 | IPR001849 | |
| Domain | DH_1 | 5.23e-03 | 63 | 104 | 3 | PS00741 | |
| Pubmed | STX8 ELOB ATAD5 UBXN8 SPART SLU7 HNRNPUL1 PLXNB2 DNAJB14 ESF1 STT3B EFR3A PLEKHG1 PTPN2 ASPH GNL2 MACF1 OS9 CTNNA1 HSPA6 QRSL1 CUX1 GOLGA4 | 1.53e-10 | 1487 | 108 | 23 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX SMC1A RSF1 ACOT7 SLU7 RIOK3 CHD2 VPS16 HNRNPUL1 KIF20B NKRF ESF1 DST ASPH SMARCA1 SF3A3 CSTA SMARCC1 MACF1 HSPA6 GOLGA4 PMM2 | 1.60e-10 | 1353 | 108 | 22 | 29467282 |
| Pubmed | ELOB SETX ATAD5 ARHGEF12 CHD2 CIT KIF20B NKRF GGCX ESF1 STT3B EPN2 EFR3A DST MTA3 IFRD2 ASPH GNL2 MACF1 OS9 ZC3H7B HSPA6 | 1.06e-09 | 1497 | 108 | 22 | 31527615 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX ESS2 ATAD5 SMC1A SMC6 RSF1 CHD2 KIF20B MTA3 GNL2 SMARCA1 SMARCC1 CUX1 | 5.67e-08 | 608 | 108 | 13 | 36089195 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ANXA4 SPTB CHD2 GTF2IRD1 SHTN1 SIL1 SH3YL1 ARHGAP6 FAM111A MTA3 TTC12 ASPH FNIP1 MACF1 OS9 MCF2L TMEM181 CUX1 GOLGA4 | 1.56e-07 | 1489 | 108 | 19 | 28611215 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EPN3 ANXA4 PDAP1 ARHGEF12 GLOD4 SHTN1 EPN2 EFR3A DST MACF1 CTNNA1 CNN2 | 2.04e-07 | 565 | 108 | 12 | 25468996 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ELOB SETX SMC1A PDAP1 CHD2 HNRNPUL1 GTF2IRD1 NKRF STT3B DST VCAN GNL2 SF3A3 SMARCC1 MACF1 HSPA6 | 2.40e-07 | 1082 | 108 | 16 | 38697112 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETX ATAD5 SMC1A SMC6 RSF1 PDAP1 SLU7 HNRNPUL1 KIF20B NKRF ESF1 GNL2 SF3A3 SMARCC1 CUX1 | 2.74e-07 | 954 | 108 | 15 | 36373674 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SMC1A SLU7 HNRNPUL1 CIT KIF20B NKRF ESF1 STT3B PTPN2 DST MTA3 ASPH GNL2 SMARCA1 SF3A3 CSTA CTNNA1 | 3.41e-07 | 1257 | 108 | 17 | 36526897 |
| Pubmed | AVEN ACOT7 NKRF AREG DST MTA3 SMARCC1 MACF1 OS9 CTNNA1 GSTO1 RGL2 | 6.89e-07 | 634 | 108 | 12 | 34591612 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOB ATAD5 RSF1 ACOT7 PDAP1 SPART GLOD4 HNRNPUL1 SHTN1 NKRF ESF1 DST GNL2 MACF1 | 1.24e-06 | 934 | 108 | 14 | 33916271 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPN3 KIAA0513 MTMR8 GTF2IRD1 PLXNB2 CIT TBC1D9 SIL1 TBC1D16 PLEKHG1 DST IFRD2 MCF2L ZC3H7B RGL2 | 1.71e-06 | 1105 | 108 | 15 | 35748872 |
| Pubmed | 2.05e-06 | 187 | 108 | 7 | 26460568 | ||
| Pubmed | 2.15e-06 | 469 | 108 | 10 | 27634302 | ||
| Pubmed | STX8 ELOB PDAP1 HNRNPUL1 IFIT1 NKRF STT3B ANKRD13A DST ASPH GNL2 SF3A3 CSTA OS9 CTNNA1 HSPA6 CUX1 | 2.19e-06 | 1440 | 108 | 17 | 30833792 | |
| Pubmed | UBXN8 RSF1 PDAP1 CHD2 TEX14 DNAJB14 ESF1 STT3B PRDM8 DST SMARCA1 SMARCC1 MACF1 MCF2L DNAH6 HSPA6 CUX1 | 2.23e-06 | 1442 | 108 | 17 | 35575683 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX ESS2 KIAA0513 SMC1A ACOT7 SLU7 NKRF TTLL7 SMARCA1 SF3A3 CSTA SMARCC1 CUX1 | 2.69e-06 | 857 | 108 | 13 | 25609649 |
| Pubmed | 3.60e-06 | 497 | 108 | 10 | 23414517 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ATAD5 SMC1A SMC6 SLU7 HNRNPUL1 KIF20B NKRF ESF1 ASPH GNL2 MACF1 ZC3H7B | 4.41e-06 | 759 | 108 | 12 | 35915203 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ANXA4 ACOT7 PDAP1 SPART GLOD4 HNRNPUL1 PLXNB2 IFIT1 DNAJB14 ANKRD13A PTPN2 SF3A3 SMARCC1 CTNNA1 CNN2 PMM2 | 5.02e-06 | 1367 | 108 | 16 | 32687490 |
| Pubmed | KIAA0513 ARHGEF12 PLEKHG1 CADPS FNIP1 MACF1 MCF2L TMEM181 PLCE1 | 5.31e-06 | 407 | 108 | 9 | 12693553 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22589727 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33454014 | ||
| Pubmed | Shootin1 acts in concert with KIF20B to promote polarization of migrating neurons. | 9.55e-06 | 2 | 108 | 2 | 23864681 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15265687 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27732084 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11002341 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15937072 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 36446235 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20138207 | ||
| Pubmed | Identification and validation of Ifit1 as an important innate immune bottleneck. | 9.55e-06 | 2 | 108 | 2 | 22745654 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23824812 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27823966 | ||
| Pubmed | A viral RNA structural element alters host recognition of nonself RNA. | 9.55e-06 | 2 | 108 | 2 | 24482115 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10444334 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33075816 | ||
| Pubmed | Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. | 9.55e-06 | 2 | 108 | 2 | 24098121 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27240734 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25927359 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30282041 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26157117 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28193719 | ||
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 9.55e-06 | 2 | 108 | 2 | 30578315 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26459629 | ||
| Pubmed | Postnatal gene expression in the normal mouse cornea by SAGE. | 1.03e-05 | 14 | 108 | 3 | 14744882 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ELOB SETX ATAD5 SMC1A CHD2 HNRNPUL1 GTF2IRD1 NKRF STT3B DST ASPH SF3A3 SMARCC1 HSPA6 CUX1 | 1.14e-05 | 1294 | 108 | 15 | 30804502 |
| Pubmed | 1.15e-05 | 568 | 108 | 10 | 37774976 | ||
| Pubmed | ELOB SETX ATAD5 SMC6 HNRNPUL1 GTF2IRD1 KIF20B FAM111A SMARCC1 | 1.25e-05 | 453 | 108 | 9 | 29656893 | |
| Pubmed | SMC1A PDAP1 ARHGEF12 SPART SHTN1 STT3B EFR3A DST MACF1 CTNNA1 GOLGA4 | 1.33e-05 | 708 | 108 | 11 | 39231216 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.98e-05 | 605 | 108 | 10 | 28977666 | |
| Pubmed | STX8 AVEN SETX ANXA4 CHD2 NKRF GGCX FAM111A AFP ASPH GNL2 SMARCA1 CSTA SMARCC1 CNN2 | 2.25e-05 | 1371 | 108 | 15 | 36244648 | |
| Pubmed | ELOB ESS2 SMC1A ARHGEF12 GLOD4 PLEKHG1 ARHGAP6 CSTA SMARCC1 CTNNA1 MCF2L GOLGA4 | 2.85e-05 | 916 | 108 | 12 | 32203420 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 7896268 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 2.86e-05 | 3 | 108 | 2 | 12399109 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 8268909 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 30232164 | ||
| Pubmed | Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. | 2.86e-05 | 3 | 108 | 2 | 15561726 | |
| Pubmed | Novel characteristics of the function and induction of murine p56 family proteins. | 2.86e-05 | 3 | 108 | 2 | 18768971 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 35034537 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 19856081 | ||
| Pubmed | Secondary PDZ domain-binding site on class B plexins enhances the affinity for PDZ-RhoGEF. | 2.86e-05 | 3 | 108 | 2 | 26627240 | |
| Pubmed | 3.19e-05 | 20 | 108 | 3 | 34220450 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNAH10 SMC1A SMC6 GLOD4 HNRNPUL1 CMYA5 ESF1 STT3B GBA3 GNL2 SMARCA1 SF3A3 CSTA SMARCC1 GOLGA4 | 3.50e-05 | 1425 | 108 | 15 | 30948266 |
| Pubmed | 3.78e-05 | 653 | 108 | 10 | 22586326 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 4.21e-05 | 298 | 108 | 7 | 32353859 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 4.47e-05 | 411 | 108 | 8 | 35182466 | |
| Pubmed | SMC1A SPTB SYNC HNRNPUL1 CMYA5 SHTN1 CIT SH3YL1 DST MTA3 CADPS MACF1 CTNNA1 CUX1 | 4.52e-05 | 1285 | 108 | 14 | 35914814 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 23349951 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 24991014 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 24198415 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 24478444 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 17079283 | ||
| Pubmed | Interferon-induced Ifit proteins: their role in viral pathogenesis. | 5.71e-05 | 4 | 108 | 2 | 25428874 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 8660659 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 8954775 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 15496924 | ||
| Pubmed | Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. | 5.71e-05 | 4 | 108 | 2 | 17553874 | |
| Pubmed | Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon. | 5.71e-05 | 4 | 108 | 2 | 25231314 | |
| Pubmed | The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion. | 5.71e-05 | 4 | 108 | 2 | 20709745 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 37496288 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 11567631 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 11175280 | ||
| Pubmed | 5.74e-05 | 313 | 108 | 7 | 20800603 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ELOB SMC1A ACOT7 PDAP1 SPART HNRNPUL1 SHTN1 ESF1 DST SF3A3 MACF1 GSTO1 HSPA6 | 5.89e-05 | 1149 | 108 | 13 | 35446349 |
| Pubmed | ELOB ATAD5 ANXA4 SMC1A SMC6 RSF1 CHD2 NKRF ESF1 PTPN2 MTA3 SMARCC1 | 7.56e-05 | 1014 | 108 | 12 | 32416067 | |
| Pubmed | 8.15e-05 | 228 | 108 | 6 | 30471916 | ||
| Pubmed | 8.80e-05 | 723 | 108 | 10 | 34133714 | ||
| Pubmed | Rabl2 GTP hydrolysis licenses BBSome-mediated export to fine-tune ciliary signaling. | 9.50e-05 | 5 | 108 | 2 | 33241915 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 29879406 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 27137933 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 12183458 | ||
| Pubmed | A molecular network for the transport of the TI-VAMP/VAMP7 vesicles from cell center to periphery. | 9.50e-05 | 5 | 108 | 2 | 22705394 | |
| Pubmed | Ifit2 Is a Restriction Factor in Rabies Virus Pathogenicity. | 9.50e-05 | 5 | 108 | 2 | 28637751 | |
| Pubmed | Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. | 9.50e-05 | 5 | 108 | 2 | 22615570 | |
| Pubmed | 9.78e-05 | 591 | 108 | 9 | 15231748 | ||
| Pubmed | ZGRF1 ANXA4 SPTB CHD2 PLXNB2 TBC1D9 TBC1D16 FAM228B RABL2A VCAN OS9 USP35 GSTO1 | 1.03e-04 | 1215 | 108 | 13 | 15146197 | |
| Pubmed | 1.09e-04 | 467 | 108 | 8 | 30194290 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 1.24e-04 | 754 | 108 | 10 | 33060197 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ELOB SMC1A PDAP1 GLOD4 HNRNPUL1 ASPH GNL2 SF3A3 SMARCC1 MACF1 CTNNA1 HSPA6 CNN2 GOLGA4 | 1.25e-04 | 1415 | 108 | 14 | 28515276 |
| Pubmed | 1.32e-04 | 615 | 108 | 9 | 31048545 | ||
| Interaction | CIT interactions | SETX SMC1A SPTB RSF1 CHD2 HNRNPUL1 CMYA5 CIT NKRF ESF1 FAM228B MTA3 ASPH GNL2 SMARCA1 SF3A3 SMARCC1 MACF1 CTNNA1 HSPA6 CNN2 CUX1 GOLGA4 | 2.07e-06 | 1450 | 108 | 23 | int:CIT |
| Interaction | H3C3 interactions | SETX ESS2 ATAD5 SMC1A SMC6 RSF1 KIF20B MTA3 GNL2 SMARCA1 SMARCC1 CUX1 | 1.39e-05 | 495 | 108 | 12 | int:H3C3 |
| Cytoband | 10q23.31 | 7.18e-05 | 34 | 108 | 3 | 10q23.31 | |
| GeneFamily | RAB like GTPases | 1.23e-04 | 5 | 64 | 2 | 394 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 2.56e-04 | 7 | 64 | 2 | 761 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.41e-04 | 8 | 64 | 2 | 939 | |
| GeneFamily | UPF1 like RNA helicases | 6.65e-04 | 11 | 64 | 2 | 1169 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.35e-04 | 115 | 64 | 4 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.08e-04 | 206 | 64 | 5 | 682 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.73e-04 | 53 | 64 | 3 | 532 | |
| GeneFamily | Dyneins, axonemal | 1.62e-03 | 17 | 64 | 2 | 536 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.65e-03 | 66 | 64 | 3 | 722 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | ESS2 SMC1A CHD2 SYNC HNRNPUL1 PLXNB2 GGCX VCAN SMARCC1 OS9 ZC3H7B GOLGA4 | 6.73e-08 | 389 | 107 | 12 | M6520 |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 2.55e-07 | 14 | 107 | 4 | M2576 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 2.55e-07 | 14 | 107 | 4 | MM961 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SETX SMC6 RSF1 SLU7 SHTN1 DNAJB14 KIF20B TBC1D9 ESF1 TTLL7 FAM111A GOLGA4 ENOX2 | 2.82e-06 | 656 | 107 | 13 | M18979 |
| Coexpression | GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.86e-05 | 200 | 107 | 7 | M9164 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX SPART KIF20B BDNF EFR3A PTPN2 DST SMARCA1 MACF1 CUX1 GOLGA4 PLCE1 PMM2 | 4.69e-05 | 856 | 107 | 13 | M4500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ATAD5 ZGRF1 SMC1A SMC6 PDAP1 ARHGEF12 SLU7 CHD2 HNRNPUL1 GTF2IRD1 CIT KIF20B NKRF ESF1 EPN2 PTPN2 GNL2 MACF1 | 2.07e-09 | 629 | 106 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ATAD5 SMC1A SMC6 PDAP1 CHD2 GTF2IRD1 CIT KIF20B NKRF ESF1 CUX1 GOLGA4 | 5.08e-08 | 311 | 106 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ATAD5 SMC1A SMC6 PDAP1 SEC11C GTF2IRD1 CIT KIF20B NKRF ESF1 GNL2 MACF1 | 1.69e-06 | 432 | 106 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DNAH10 ATAD5 SMC1A SMC6 PDAP1 ARHGEF12 SEC11C GTF2IRD1 CIT KIF20B NKRF ESF1 EFR3A SH3RF2 GNL2 MACF1 RGL2 TMEM181 | 1.82e-06 | 989 | 106 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ATAD5 SMC1A SMC6 PDAP1 CHD2 GTF2IRD1 PLXNB2 CIT KIF20B NKRF ESF1 RABL2A FNIP1 CUX1 GOLGA4 PMM2 | 3.59e-06 | 831 | 106 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SETX ATAD5 SMC1A RSF1 PDAP1 CIT KIF20B NKRF ESF1 DST GNL2 SMARCC1 | 3.94e-06 | 469 | 106 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.47e-06 | 192 | 106 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.47e-06 | 192 | 106 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.23e-06 | 203 | 106 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SETX ATAD5 SMC6 RSF1 PDAP1 CIT KIF20B NKRF ESF1 FAM111A SMARCC1 QRSL1 | 1.40e-05 | 532 | 106 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ATAD5 ZGRF1 SMC1A SLU7 CHD2 HNRNPUL1 GTF2IRD1 ESF1 EPN2 PTPN2 GNL2 MACF1 | 2.50e-05 | 564 | 106 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SMC1A PDAP1 ARHGEF12 CHD2 PLXNB2 CIT KIF20B RABL2A GNL2 SMARCA1 FNIP1 MACF1 CUX1 PMM2 | 3.35e-05 | 780 | 106 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.01e-05 | 185 | 106 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | RNF34 SHTN1 SIL1 ANKRD13A DST CADPS VCAN SMARCA1 ZC3H7B PLCE1 | 7.27e-05 | 441 | 106 | 10 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.44e-05 | 204 | 106 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ATAD5 SMC1A SMC6 PDAP1 CHD2 GTF2IRD1 CIT KIF20B NKRF ESF1 RABL2A IFRD2 TMEM181 CUX1 GOLGA4 | 1.16e-04 | 989 | 106 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | SMC1A PDAP1 ARHGEF12 P4HA3 GTF2IRD1 CIT KIF20B GNL2 MACF1 TMEM181 | 1.78e-04 | 492 | 106 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZGRF1 SMC1A ARHGEF12 SLU7 CHD2 HNRNPUL1 ESF1 EPN2 GNL2 MACF1 GOLGA4 | 1.91e-04 | 595 | 106 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | SETX ATAD5 DNAJB14 BDNF TTLL7 EFR3A ARHGAP6 FAM111A VCAN ASPH SMARCA1 FNIP1 CUX1 | 2.40e-04 | 826 | 106 | 13 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.02e-04 | 339 | 106 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | ATAD5 SMC1A ARHGEF12 RIOK3 SEC11C HNRNPUL1 GTF2IRD1 EFR3A PTPN2 IFRD2 GNL2 MACF1 RGL2 TMEM181 | 3.78e-04 | 983 | 106 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 3.96e-04 | 124 | 106 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | ANXA4 RNF34 SHTN1 SIL1 ANKRD13A DST MTA3 CADPS VCAN SMARCA1 OS9 ZC3H7B PLCE1 | 4.59e-04 | 884 | 106 | 13 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SETX ATAD5 SMC1A SMC6 RSF1 PDAP1 P4HA3 CIT KIF20B NKRF ESF1 VCAN KCNJ15 ASPH GNL2 SMARCC1 | 4.71e-04 | 1252 | 106 | 16 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SETX ATAD5 ZGRF1 SMC1A SMC6 RSF1 PDAP1 CIT KIF20B NKRF ESF1 KCNJ15 GNL2 SMARCC1 MACF1 CUX1 | 4.92e-04 | 1257 | 106 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.19e-08 | 200 | 108 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.19e-08 | 200 | 108 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-07 | 193 | 108 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-07 | 195 | 108 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-07 | 195 | 108 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 184 | 108 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 186 | 108 | 6 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 186 | 108 | 6 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.40e-06 | 187 | 108 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.81e-06 | 189 | 108 | 6 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-06 | 193 | 108 | 6 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.14e-06 | 195 | 108 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-06 | 197 | 108 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | VE-mDC2-|VE / Condition, Cell_class and T cell subcluster | 8.62e-06 | 197 | 108 | 6 | 6629588819ec31a7e4f33b94b8c035145a5f6c17 | |
| ToppCell | VE-mDC2|VE / Condition, Cell_class and T cell subcluster | 8.62e-06 | 197 | 108 | 6 | e3172102ad17c92c3038cad37bf933eb04351048 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.87e-06 | 198 | 108 | 6 | 374d7a24e00cd3f435ca980123ab3c6a441c9ad5 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.87e-06 | 198 | 108 | 6 | f3346c26b9647a199faf3cd7ab19c3a963dbabc2 | |
| ToppCell | PSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.13e-06 | 199 | 108 | 6 | 2add64c3e4cb6384ec381f34c3f1f77e13e3f27c | |
| ToppCell | control-Myeloid-CD14_Monocytes_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.13e-06 | 199 | 108 | 6 | 8c14237c3da91d1a4878df489a495408a1e83883 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | mild-Myeloid-CD14_Monocytes_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.40e-06 | 200 | 108 | 6 | 3874c1f078cb8789be2e2275a202357c711b1be3 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.05e-05 | 148 | 108 | 5 | 6ffa212f0cc44c40d2143816dc6cfd82fbf09a33 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.58e-05 | 153 | 108 | 5 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-05 | 153 | 108 | 5 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 154 | 108 | 5 | 2d98bb7a784fc3215e0d4a1670d662e5df4716c3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 154 | 108 | 5 | 0dec222101530f1727184dbb7c03969d3884f111 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.13e-05 | 165 | 108 | 5 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-05 | 167 | 108 | 5 | 1cd9e2af85c6c5b9e1d88991c87ac6980b387243 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-05 | 168 | 108 | 5 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.08e-05 | 171 | 108 | 5 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-05 | 171 | 108 | 5 | f2b31c97bbcc5164fc279ed0362007878887ad5e | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 176 | 108 | 5 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.74e-05 | 180 | 108 | 5 | 2bc3fd2e4c249bf236340c5f0483747faa5c04ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.95e-05 | 181 | 108 | 5 | 1b4eb044825ede6361928442524b1988c8ef58b3 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 181 | 108 | 5 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.95e-05 | 181 | 108 | 5 | 8d7ebbedc373d55e29da02ac2728b4f4118038f2 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 8.59e-05 | 184 | 108 | 5 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.59e-05 | 184 | 108 | 5 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.59e-05 | 184 | 108 | 5 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.59e-05 | 184 | 108 | 5 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 8.59e-05 | 184 | 108 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.81e-05 | 185 | 108 | 5 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.81e-05 | 185 | 108 | 5 | 5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.81e-05 | 185 | 108 | 5 | 100b5afdf3c6ab07ffc493f7883f5a7b31c59184 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class | 8.81e-05 | 185 | 108 | 5 | 30f064ab7c3890e6f419a845276b145112e78f52 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.81e-05 | 185 | 108 | 5 | f3b1907c3b6f930bc161f46efce5e143babab507 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.81e-05 | 185 | 108 | 5 | 44ce50cb99df8ffc50eba311adcf688477618659 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.81e-05 | 185 | 108 | 5 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.81e-05 | 185 | 108 | 5 | 17542ccd52a821c9e99b1a7469e80502e764b3fd | |
| ToppCell | COVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class | 8.81e-05 | 185 | 108 | 5 | 3ed6090b822c6d1d400a421236cddc7511743932 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | 18c06041c6c8a0ebac17b3c8aaebd67e652d315a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 187 | 108 | 5 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 187 | 108 | 5 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 9.27e-05 | 187 | 108 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.27e-05 | 187 | 108 | 5 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.50e-05 | 188 | 108 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | 533685a921a65d84107d8d33c43b4fffde019143 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-05 | 189 | 108 | 5 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.74e-05 | 189 | 108 | 5 | cce6602ad68c177985a5e43cfb2776d615cfbca0 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | dca56ab02bf0505f9a352ff907edaef30906d854 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 9.74e-05 | 189 | 108 | 5 | 74a5e61cd820f2495dde40e766c771a31d8c4e7d | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 9.74e-05 | 189 | 108 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 9.74e-05 | 189 | 108 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | facs-Marrow-KLS-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-05 | 190 | 108 | 5 | a513c1e7df62c28128c932a68b252ee8f0255172 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.99e-05 | 190 | 108 | 5 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.99e-05 | 190 | 108 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.99e-05 | 190 | 108 | 5 | 4b9bac17eb7ceadada932f2d4a20a5f176088d53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.99e-05 | 190 | 108 | 5 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 191 | 108 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 191 | 108 | 5 | 81f77bf497b8e0ae0affe7d5f4f00446547229f6 | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 1.05e-04 | 192 | 108 | 5 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | NS-critical-d_0-4-Epithelial-Basal|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-04 | 193 | 108 | 5 | 1affb4c2e21712bde0d36ab736411fe36642cc6d | |
| ToppCell | COVID-19-Myeloid-TRAM1|Myeloid / Condition, Lineage and Cell class | 1.07e-04 | 193 | 108 | 5 | 6e6a7f4e50c8ae70bc187b9ce77140a7049dd288 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.07e-04 | 193 | 108 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 194 | 108 | 5 | 2b5eee7c3e52b63cce94205d18133c7704329c02 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 194 | 108 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 194 | 108 | 5 | 12e42433a7b7c17c46049ef450223daf2976a59a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 194 | 108 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 194 | 108 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 194 | 108 | 5 | b191851b2287afc8c47320f5488fd22e2a454aa6 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-late_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 194 | 108 | 5 | 23b06707d21306b4483d64cb350b86aef352ce38 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.13e-04 | 195 | 108 | 5 | 19413dc6aa0010686cdfa0c750ef0a7a76caf308 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 195 | 108 | 5 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-04 | 195 | 108 | 5 | 4e9513a7ea69fa9fc8e9ff2da8ef3f44e8fdc70d | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.83e-05 | 50 | 71 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | open-angle glaucoma | 5.78e-05 | 191 | 103 | 6 | EFO_0004190 | |
| Disease | cortical surface area measurement | STX8 ARHGEF12 SYNC SHTN1 PLXNB2 KIF20B TBC1D16 PLEKHG1 CADPS VCAN MACF1 USP35 CUX1 PLCE1 | 2.42e-04 | 1345 | 103 | 14 | EFO_0010736 |
| Disease | Ataxias, Hereditary | 3.33e-04 | 8 | 103 | 2 | C0004138 | |
| Disease | Antihypertensive use measurement | 3.42e-04 | 265 | 103 | 6 | EFO_0009927 | |
| Disease | Immature Reticulocyte Fraction Measurement | 5.33e-04 | 10 | 103 | 2 | EFO_0009253 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 6.77e-04 | 49 | 103 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | ADHD symptom measurement | 7.78e-04 | 12 | 103 | 2 | EFO_0007860 | |
| Disease | coronary artery disease | DNAH10 ARHGEF12 CHD2 HNRNPUL1 BDNF GGCX PLEKHG1 PRDM8 GPR149 SF3A3 MCF2L PLCE1 | 9.39e-04 | 1194 | 103 | 12 | EFO_0001645 |
| Disease | Tobacco Dependence | 1.07e-03 | 14 | 103 | 2 | C0040332 | |
| Disease | Nicotine Dependence | 1.07e-03 | 14 | 103 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 1.07e-03 | 14 | 103 | 2 | C0376384 | |
| Disease | body weights and measures, body height | 1.23e-03 | 15 | 103 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | alcohol consumption measurement | CACNA1D RIOK3 P4HA3 CIT BDNF SIL1 STT3B CADPS TTC12 CTNNA1 ZC3H7B CUX1 | 1.31e-03 | 1242 | 103 | 12 | EFO_0007878 |
| Disease | preeclampsia, hypertension, pregnancy-induced | 1.40e-03 | 16 | 103 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | Headache | 1.47e-03 | 64 | 103 | 3 | HP_0002315 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.59e-03 | 17 | 103 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.59e-03 | 17 | 103 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.59e-03 | 17 | 103 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.59e-03 | 17 | 103 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.59e-03 | 17 | 103 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.59e-03 | 17 | 103 | 2 | C0751781 | |
| Disease | cortical thickness | STX8 ARHGEF12 GLOD4 SHTN1 KIF20B PLEKHG1 CADPS VCAN MACF1 USP35 PLCE1 | 1.76e-03 | 1113 | 103 | 11 | EFO_0004840 |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.78e-03 | 18 | 103 | 2 | C0751779 | |
| Disease | Deaf Mutism | 2.20e-03 | 20 | 103 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 2.20e-03 | 20 | 103 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 2.20e-03 | 20 | 103 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 2.20e-03 | 20 | 103 | 2 | C0581883 | |
| Disease | Prelingual Deafness | 2.20e-03 | 20 | 103 | 2 | C0011052 | |
| Disease | Bilateral Deafness | 2.20e-03 | 20 | 103 | 2 | C3665473 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 2.24e-03 | 74 | 103 | 3 | EFO_0007869, EFO_0007878 | |
| Disease | Epilepsy, Cryptogenic | 3.00e-03 | 82 | 103 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.00e-03 | 82 | 103 | 3 | C0751111 | |
| Disease | Aura | 3.00e-03 | 82 | 103 | 3 | C0236018 | |
| Disease | Deafness | 3.44e-03 | 25 | 103 | 2 | C0011053 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEEEGRKRYEAQKLE | 186 | O00154 | |
| QKDLNEKCLYEVGRD | 426 | Q96QE3 | |
| QYDKDNEKRTLLQCE | 161 | P0C875 | |
| YEGEAEERKKLRQEN | 231 | P15514 | |
| KVRPNEENNKDADLY | 76 | P23560 | |
| LGQFERTQEEYEDKK | 2741 | P13611 | |
| LKDFQYIDRDGKDQG | 106 | Q9H201 | |
| LIGDNDNAKKVYEEV | 466 | Q12797 | |
| RFQEELGYDLKENAK | 51 | Q8IYM0 | |
| VRQDAQDLYEAGEKK | 171 | P09525 | |
| VGEYAKLEKINAEQQ | 621 | O14578 | |
| LGCKEEDNVQKNYEL | 536 | Q14156 | |
| QAVKEAENKQRLEDY | 976 | Q9NZN5 | |
| NKEEKDVNLRISGNY | 1401 | Q9NZN5 | |
| EKYNGNRIGLEEEKL | 311 | P17706 | |
| ENIRALKDGYEKVEQ | 111 | Q7Z4N8 | |
| KQAVIGNLDEEQYKL | 386 | O60268 | |
| LDQGKYDADDNVKII | 11 | Q9UBK7 | |
| LDQGKYDADDNVKII | 11 | Q9UNT1 | |
| DYRQLEKELQGQNVE | 21 | Q8IZ07 | |
| YAKIEENQKDAENVG | 856 | Q9ULU8 | |
| DTGVRNEAQEEIYKK | 186 | Q13823 | |
| EEKNIALNGEYGKEL | 171 | A8MXD5 | |
| IRSQNKEDYAGLKEE | 131 | P78417 | |
| EEDDYQQKRKGVEGL | 66 | Q13442 | |
| GNCQKDREDLRVYEK | 441 | Q96EF0 | |
| KDEEKQRALLGYADN | 181 | Q9HC38 | |
| QVYESKLEDGNKEQE | 886 | Q13439 | |
| RQQEYKEKLQGICDL | 3641 | Q03001 | |
| LKDFQYIDRDGKDQG | 106 | O95208 | |
| EQAKRNLEGEIQNYK | 411 | Q5T655 | |
| NLEGEIQNYKDEAQK | 416 | Q5T655 | |
| DAYRNEVELLKQEQG | 426 | Q16206 | |
| NQKLRETLEEYNKEF | 126 | Q13948 | |
| QLEEKLKGQADYEEV | 351 | Q13948 | |
| SQKDDEEQIAKYRQL | 571 | Q9H501 | |
| QAEREYEKIKSQLEG | 1226 | O15031 | |
| TQNLKADLQRKEEDY | 1271 | Q96Q89 | |
| DELQESEQKYNADRK | 1446 | Q96Q89 | |
| SEKQQLEEKYRQEDQ | 346 | Q99712 | |
| CEGRDLDDKIQEYKQ | 111 | Q8NG66 | |
| EGLDKLVSDANEQYK | 1766 | O94854 | |
| NYSELREDIQTKGKE | 51 | Q9UN81 | |
| ERDGYQEEIQLLNKA | 706 | Q86SP6 | |
| DRAYKLKQDLQRDEQ | 291 | O43182 | |
| KLQAQKEYLEAEENG | 61 | Q96DF8 | |
| LYQAEEEFEKRQKDN | 181 | Q96DF8 | |
| LQDEYDKGVNEKESL | 2936 | Q9C0G6 | |
| GNEKEVKEYAQVFRE | 411 | P35221 | |
| YQENKKGELGILQDA | 316 | Q9H227 | |
| QAEESEKRYKNGQSL | 51 | Q9H0R6 | |
| EQRLYKDDQLLDDGK | 41 | Q15370 | |
| EENDEQGNYSKRKIV | 101 | Q9NQS1 | |
| QEYEEQLKENASEGK | 1186 | O14647 | |
| NPEKRKQYDLTGNEE | 161 | Q8TBM8 | |
| QEENAVDVKQYRDKL | 656 | Q8TF40 | |
| EELDYAVLKLKENGQ | 436 | Q96PZ2 | |
| LSDQDEEGKIKQEYI | 51 | Q8N3K9 | |
| KLQDEGQEAEGEKYI | 226 | Q5T764 | |
| VLTGYQVDKNKDDEL | 81 | P01040 | |
| QGQQEDLEEKLKEYV | 131 | Q12894 | |
| GAENKIQELNAIYKE | 506 | O15068 | |
| KLQDEGQEAEGEKYI | 226 | P09914 | |
| IYDQRRIDKKENNGV | 361 | A6NGE4 | |
| NQLAEKEEYEHQKRE | 586 | P17066 | |
| REQVQDLFNKKYGEA | 706 | Q9UHL9 | |
| LDSDRGQEVKQKYLE | 596 | Q8IVF4 | |
| RDDYIGQVAKEIENK | 4196 | Q8IVF4 | |
| QKRQINYKEDSESDG | 1211 | Q96T23 | |
| REKQQLEEDLKGYLD | 426 | Q01668 | |
| KGEEELQKYIQESQA | 396 | P02771 | |
| EADKLVRQYNEEGRK | 586 | Q9BUJ2 | |
| EALEKYGKDFNDIRQ | 281 | Q9BTC8 | |
| KVQEQLGNDVVEKYD | 51 | O15305 | |
| EELAQLRDAYQKQKE | 286 | Q9H7C4 | |
| SKDELENGYINFDKR | 446 | O15211 | |
| QLGNSKEDKEADYRV | 376 | Q96M34 | |
| KGDNNEVDDRGLYKE | 126 | Q9BY50 | |
| EIYNAESRNKDDGKV | 916 | Q8IWB6 | |
| RGKEAEEQRQKEAYL | 931 | A5PKW4 | |
| NQFIKANEKYGRDDI | 866 | P28370 | |
| AEEAYKQQIKEDNIG | 541 | O15226 | |
| GEEFYLDQNKKESRQ | 1646 | Q9P212 | |
| RDKEEQNLEAYIKNG | 96 | Q9NQV8 | |
| TEKYENEGQRINARK | 211 | Q96HL8 | |
| GDNNEQNYIKDVKLE | 666 | Q7Z333 | |
| QTGEREAKLQYEDKF | 96 | Q9H173 | |
| IGEYEDLRAENQKTK | 21 | A0MZ66 | |
| AREIGDKQERKYNQL | 1236 | Q6ZUB1 | |
| LYGKRRSQKEEDEQE | 351 | Q92922 | |
| RQADSKQYGDKIIEE | 261 | Q13438 | |
| DIGVKYSEKQERNFD | 141 | Q99439 | |
| EYDAQLRREEKKFNG | 91 | O14730 | |
| LNTDELGQKEEAKNY | 31 | Q8N0X7 | |
| AYLQELKEKVENGSE | 616 | P38435 | |
| KENEENQKSYGERLQ | 301 | Q969K3 | |
| NQKSYGERLQLQDEE | 306 | Q969K3 | |
| QNGQAIRAKYKEESD | 596 | Q9P2C4 | |
| EDDKRNQGNLYDKAG | 501 | Q8TCJ2 | |
| KDNILYLQEQEKEAR | 956 | Q9P2H5 | |
| NELGQVEEEYKLRKA | 406 | Q8TBP0 | |
| QKADEYLREIQELGQ | 361 | Q9H269 | |
| GIIAEYNKINDVKED | 121 | Q6ZT07 | |
| QGRDLTLEENQVKKY | 361 | Q14683 | |
| VRLNEAEQKYKDIQD | 316 | Q96SB8 | |
| EQQKESILEKYGGQE | 366 | O95391 | |
| AEKIQQRNQYERKGE | 21 | Q9UNK0 | |
| YAGEKAEAIQNKEQE | 1866 | P11277 | |
| ERKKYNVDQSVGNND | 381 | Q86YA3 | |
| VKGYLNQVDLQEKAD | 211 | Q9H892 | |
| YNFDLRGKDKSENQD | 196 | Q8TEC5 | |
| YDDKDGLRKEELNAI | 61 | Q12874 | |
| DLENYIKKNEDKARD | 841 | Q9ULL1 | |
| KQQEAQGEKASRYIE | 86 | O00124 | |
| ESDENEKEEYQNKKR | 561 | Q6ZT98 | |
| AEGNDLFREKDYKQA | 41 | Q9UGR2 |